Pesquisar
Neurosense Therapeutics Ltd
NRSNWAdicionar à lista de desejos
0.130USD
+0.063+94.03%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
0.00Valor de mercado
--P/L TTM
Mais detalhes de Neurosense Therapeutics Ltd Empresa
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Informações de Neurosense Therapeutics Ltd
Código da empresaNRSNW
Nome da EmpresaNeurosense Therapeutics Ltd
Data de listagemDec 09, 2021
CEOMr. Alon Ben-Noon
Número de funcionários- -
Tipo de títulosCompany Warrant
Fim do ano fiscal- -
Endereço11 Hamenofim St.
CidadeHERZLIYA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísIsrael
Código postal4672562
Telefone97299531142
Sitehttps://www.neurosense-tx.com/
Código da empresaNRSNW
Data de listagemDec 09, 2021
CEOMr. Alon Ben-Noon
Executivos da empresa Neurosense Therapeutics Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Neurosense Therapeutics Ltd?
Os cinco principais acionistas de Neurosense Therapeutics Ltd são: Ms. Christine A. Pellizzari, J.D.